The U.S. Food and Drug Administration has declined to approve Capricor Therapeutics' cell therapy for a heart condition, the company said on Friday, sending its shares tumbling 30% in early trading.

The first session of the Al-Ahram Pharmaceutical Conference, in its fourth edition, held Saturday under the patronage of Prime Minister Mostafa Madbouly, discussed the impact of current ...

Learn about uses, side effects, dosage, and more for Izervay, a prescription drug used to treat geographic atrophy due to age-related macular degeneration.